Search research articles
Contact Us
Filters
Showing results (1-10 of 76) with videos related to
Page
of 8
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
June 15, 2020
A comparison of daptomycin alone and in combination with ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bacteremia complicated by septic pulmonary emboli
Taylor Morrisette, Abdalhamid M Lagnf, Sara Alosaimy, et al.
The Nurse Practitioner
|
November 19, 2016
Drug updates and approvals: 2016 in review
Lindsy Meadowcraft, Geoffrey Mospan, Taylor Morrisette, et al.
The American Journal of Emergency Medicine
|
April 4, 2025
Cephalexin twice daily versus four times daily for the treatment of urinary tract infections diagnosed in the emergency department
Abigail Rath, Taylor Morrisette, Aaron Hamby, et al.
Hospital Pharmacy
|
January 28, 2020
Factors Associated With Increased Hospital Length of Stay in Peritoneal Dialysis Patients With Peritonitis: A Need for Antimicrobial Stewardship?
Taylor Morrisette, Robert B Canada, Danielle Padgett, et al.
Infectious Diseases and Therapy
|
January 26, 2021
COVID-19: Before the Fall, An Evidence-Based Narrative Review of Treatment Options
Nicholas Rebold, Dana Holger, Sara Alosaimy, et al.
Journal of the American Pharmacists Association : Japha
|
October 19, 2024
Impact of a clinical pharmacist-led, artificial intelligence-supported medication adherence program on medication adherence performance, chronic disease control measures, and cost savings
Charles Worrall, David Shirley, Jeff Bullard, et al.
Pharmacotherapy
|
January 11, 2025
Creation and validation of an extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) clinical risk scoring tool for select Enterobacterales in non-urinary isolates
Jordan Jones, Taylor Morrisette, Aaron Hamby, et al.
Pharmacotherapy
|
January 25, 2024
Updates in pulmonary drug-resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM
Dana J Holger, Ali Althubyani, Taylor Morrisette, et al.
Pharmacotherapy
|
December 25, 2019
Bacteriophage Therapeutics: A Primer for Clinicians on Phage-Antibiotic Combinations
Taylor Morrisette, Razieh Kebriaei, Katherine L Lev, et al.
Drugs in Context
|
February 11, 2022
Infectious disease: how to manage Gram-positive and Gram-negative pathogen conundrums with dual beta-lactam therapy
Alireza FakhriRavari, Brenda Simiyu, Taylor Morrisette, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 76) with videos related to
Sort By:
Page
of 8
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
June 15, 2020
A comparison of daptomycin alone and in combination with ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bacteremia complicated by septic pulmonary emboli
Taylor Morrisette, Abdalhamid M Lagnf, Sara Alosaimy, et al.
The Nurse Practitioner
|
November 19, 2016
Drug updates and approvals: 2016 in review
Lindsy Meadowcraft, Geoffrey Mospan, Taylor Morrisette, et al.
The American Journal of Emergency Medicine
|
April 4, 2025
Cephalexin twice daily versus four times daily for the treatment of urinary tract infections diagnosed in the emergency department
Abigail Rath, Taylor Morrisette, Aaron Hamby, et al.
Hospital Pharmacy
|
January 28, 2020
Factors Associated With Increased Hospital Length of Stay in Peritoneal Dialysis Patients With Peritonitis: A Need for Antimicrobial Stewardship?
Taylor Morrisette, Robert B Canada, Danielle Padgett, et al.
Infectious Diseases and Therapy
|
January 26, 2021
COVID-19: Before the Fall, An Evidence-Based Narrative Review of Treatment Options
Nicholas Rebold, Dana Holger, Sara Alosaimy, et al.
Journal of the American Pharmacists Association : Japha
|
October 19, 2024
Impact of a clinical pharmacist-led, artificial intelligence-supported medication adherence program on medication adherence performance, chronic disease control measures, and cost savings
Charles Worrall, David Shirley, Jeff Bullard, et al.
Pharmacotherapy
|
January 11, 2025
Creation and validation of an extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) clinical risk scoring tool for select Enterobacterales in non-urinary isolates
Jordan Jones, Taylor Morrisette, Aaron Hamby, et al.
Pharmacotherapy
|
January 25, 2024
Updates in pulmonary drug-resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM
Dana J Holger, Ali Althubyani, Taylor Morrisette, et al.
Pharmacotherapy
|
December 25, 2019
Bacteriophage Therapeutics: A Primer for Clinicians on Phage-Antibiotic Combinations
Taylor Morrisette, Razieh Kebriaei, Katherine L Lev, et al.
Drugs in Context
|
February 11, 2022
Infectious disease: how to manage Gram-positive and Gram-negative pathogen conundrums with dual beta-lactam therapy
Alireza FakhriRavari, Brenda Simiyu, Taylor Morrisette, et al.
Page
of 8